abstract |
Disclosed herein are new heterocyclic compounds of Formula IIa: n n n n n n n n n n and compositions thereof, and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus. |